Overall Status

Completed (68)

Recruiting (43)

Not yet recruiting (34)

Unknown status (21)

Active, not recruiting (17)

Terminated (14)

Withdrawn (5)

Suspended (2)

Enrolling by invitation (1)

Phase

phase 2 (67)

phase 1 (57)

phase 1/phase 2 (31)

n/a (9)

phase 3 (5)

phase 4 (5)

phase 2/phase 3 (3)

early phase 1 (1)

Study Documents

Funder Type

Other (141)

Industry (38)

NIH (24)

U.S. Fed (2)

Study Type

Interventional (178)

Observational (25)

Observational [Patient Registry] (2)

ADCC

Showing 201 - 205 of 205

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Cancer Trial in Houston (Herceptin, GM-CSF)

Completed

Has Results

Breast Cancer

Houston, Texas

U.T.M.D. Anderson Cancer Center

Dec 4, 2012

Acute Lymphocytic Leukemia Trial in Paris (Alemtuzumab (CAMPATH 1H) associated to G-CSF)

Completed

Acute Lymphocytic Leukemia

Alemtuzumab (CAMPATH 1H) associated to G-CSF

Paris, France

Saint Antoine Hospital, Hematology Unit

Jul 25, 2012

Solid Tumors Trial in Innsbruck (Lenalidomide, Cetuximab)

Unknown status

Solid Tumors

Innsbruck, Tyrol, Austria

Medical University of Innsbruck, Department for Internal Medicin

Jul 19, 2010

Biomarkers and Early Alzheimer's Disease

Unknown status

Alzheimer's Disease

New York, New York

Center for Brain Health, Silberstein Institute, New York Univers

Sep 16, 2009

Vitiligo Trial in Taipei (foreskin from healthy adults)

Unknown status

Vitiligo

foreskin from healthy adults

Taipei, Taiwan

National Taiwan University Hospital

Sep 14, 2005